GLPG: Galapagos NV Company Short-Term Debt

Symbol and logo of brand Galapagos (GLPG)

Galapagos NV possesses a substantial liquidity reserve and financial independence driven by strategic partnerships. Short-term borrowings under one year reflect current liability trends, and this metric currently stands at 0.00. Capital is being replenished through advances and future royalties from CAR-T therapy as the company restarts its R&D cycle, focusing on decentralized drug manufacturing.

GLPG (Galapagos N.V.) Company Short-Term Debts history from 07/04/2022 to 05/08/2026

Analytical breakdowns and data insights for company Galapagos Corp (GLPG)

- current quotes and average value forecast:
Price Chart Galapagos|GLPG - Fair Value Consensus
- market capitalization information:
Market Value Galapagos NV|GLPG - Real Price to Acquire Entire Company
- shareholders' equity book value data:
Book Value per Share Galapagos|GLPG - Book Capitalization|Market Cap to Net Assets Ratio glpg.com|GLPG - Aggregate Asset Value
- debt and liquidity data:
Debt to Equity Galapagos NV|GLPG - Long-Term Liabilities to Capital|Short-Term Debt to Equity Ratio Galapagos NV|GLPG - Company Cumulative Indebtedness|Debts to Book Capitalization Galapagos NV|GLPG - Company Long-Term Loans and Borrowings|Company Short-Term Debts Galapagos|Quick Liquidity glpg.com
- net income and valuation multiples indicators:
GLPG - Final Profit
Summary company analytics:Galapagos (GLPG)
Mass-produced product of glpg.com

The stable royalty and partnership base of Galapagos NV enables efficient liquidity management, where the total amount of liabilities maturing within twelve months serves as the key parameter. This metric aggregates short-term loans and current borrowings, reflecting the company's ability to service its debt without compromising R&D developments. Analyzing the current volume of short-term loans helps investors assess the risk of working capital deficits and avoid a value trap.

Competing companies

HLN - Company Short-Term Debt|Company Short-Term Loans and Borrowings KVUE (Kenvue Inc)|Verona Pharma Corp (VRNA) - Company Short-Term Debt|Company Current Liabilities Jyong Bio|LGND (Ligand Pharmaceuticals) - Company Short-Term Debts|Company Short-Term Debts amneal.com|Company Current Liabilities PRGO (Perrigo)|ALVO (Alvotech S.A.) - Company Short-Term Loans and Borrowings|Company Short-Term Debt Liquidia Technologies LQDA|ANI Pharmaceuticals Corp (ANIP) - Short-Term Debt|MNKD: Company Current Liabilities|amphastar.com - Amount of Current Liabilities|PCRX: Company Short-Term Debts|ARS Pharmaceuticals Inc - Company Short-Term Loans and Borrowings|TBPH (Theravance) - Company Short-Term Debts|Short-Term Debt Aquestive Corp AQST|Company Short-Term Debt scPharmaceuticals Inc. (SCPH)|TECX (tectonictx.com) - Company Short-Term Loans and Borrowings|Company Short-Term Debts TNXP (Tonix Pharmaceuticals Holding Corp.)|Short-Term Indebtedness SXT Pharmaceuticals|Eupraxia Pharma - Company Short-Term Debts|BHST - Company Short-Term Debts|eXoZymes Inc (EXOZ) - Company Short-Term Debt|ORMP (Oramed Pharmaceuticals Inc.) - Company Short-Term Debt|ENTX (Entera Bio Ltd) - Company Short-Term Debts|Company Short-Term Debts MindWalk Holdings, Inc.|Company Short-Term Debt ABVC BioPharma Inc (ABVC)|CPIX: Current Liabilities|Company Short-Term Debts QNTM (Quantum BioPharma Ltd)|Company Short-Term Debts fibrogen.com FGEN|Telomir Pharmaceuticals, Inc. - Company Short-Term Debts|Short-Term Indebtedness Rani Therapeutics (RANI)|synergychc.com (SNYR) - Company Short-Term Debt|Short-Term Debt Rallybio (RLYB)|Company Short-Term Debt Lexaria Bioscience Corp|pulmatrix.com (PULM) - Short-Term Debt Volume|Company Current Liabilities PTHL (Pheton Holdings Ltd)|APM (aptorumgroup.com) - Company Short-Term Loans and Borrowings|Company Short-Term Debt Lyra Therapeutics, Inc LYRA|IBO: Company Short-Term Indebtedness|TNFA: Company Current Liabilities|YCBD: Company Short-Term Debt|PRFX: Company Short-Term Debts|Short-Term Indebtedness Altamira Therapeutics Ltd. CYTO|Company Short-Term Debt Lipella|Company Short-Term Debt OPTN|Company Short-Term Debt Pieris Pharmaceuticals (PIRS)|PROC: Current Liabilities|Company Short-Term Debts PTPI (Petros Pharmaceuticals, Inc.)|Short-Term Indebtedness Qilian International Holding Group|SLRN - Company Short-Term Debt|Current Liabilities TFFP